More Dicot Pharma AB news
Dicot Pharma ABOMXSTO: DICOT

Dicot To Carry Out Rights Issue Of SEK 210 Million

Apr 28, 2026 at 2:38 AM EDT · Issued by Dicot Pharma AB

On 6ix: 6ix.com/news/dicot-to-carry-out-rights-issue-of-sek-210-million

Dicot Pharma AB OMXSTO:DICOT:

  • INTENDS TO CARRY OUT AN 80% ALREADY SECURED RIGHTS ISSUE OF SEK 210 MILLION

  • INTENDS RIGHTS ISSUE OF UNITS TOTALING ABOUT SEK 210 MILLION

  • WARRANT EXERCISE PRICE INTENDED AT 100–150 PERCENT OF ISSUE SUBSCRIPTION PRICE

  • WARRANTS INTENDED TO BE EXERCISABLE DURING Q2 2027

Dicot Pharma AB on 6ix

Earlier from Dicot Pharma

  • Pharma publishes its Annual Report for 2025Apr 9
  • Notice of annual general meeting in DICOT Pharma ABApr 2
  • Dicot Pharma initiates tablet manufacturing ahead of phase 2b clinical studyMar 12
  • DICOT: LIB-01 demonstrated long-lasting efficacy in phase 2a, supporting further clinical developmentFeb 18
  • Dicot Pharma to present at the Oppenheimer 36th Healthcare Life Sciences ConferenceFeb 2

Later from Dicot Pharma

  • Dicot Pharma B - Q1 Net Sales Amount To Sek 0.0 MillionApr 30
  • Report from the Annual General Meeting of Dicot PharmaMay 6
  • Dicot Pharma has resolved on an 80% guaranteed rights issue of approximately SEK 210 millionMay 8
  • Dicot Pharma Resolves On Rights Issue Of About SEK 210 MlnMay 11
  • Dicot Pharma publishes prospectus in connection with the forthcoming rights issueMay 19
All Dicot Pharma news releases↗

Follow Dicot Pharma into a list and get an email when it puts out news.

Follow Dicot Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer